What it sells
Take Care of Shitty Paperwork for Expensive Drugs
Business model breakdown
Buyer: who owns the budget?
UnverifiedPharmacy owners/operations leaders at specialty and infusion pharmacies (inferred).
Trigger: what makes them buy now?
Staff turnover, 30% average prior-auth denial rate and 30+ minutes per specialty-drug prior authorization.
Workflow: what inputs become what output?
Unify intake from fax, EHR, portals and email; verify coverage and patient cost; validate medical necessity; automate prior authorization submission.
Economics: what it saves and how it charges
Claims 97% less staff time, 95% fewer errors, 50% faster time to fill; ROI vs manual labour and delays.
Distribution: how it reaches customers
Demo-led (book a demo, ROI calculator on request), case studies, pharmacy operators podcast.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.